Related Experiment Video
Updated: Aug 18, 2026
Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
Growth and hormonal status of children treated for brain tumours
Insights
Childhood brain tumor survivors often experience short stature due to factors like growth hormone (GH) deficiency. Preliminary findings indicate that GH therapy may improve growth rates in these patients.
Area of Science:
- Pediatric Oncology
- Endocrinology
- Radiation Oncology
Background:
- Childhood brain tumor survivors frequently exhibit short stature.
- Impaired growth is multifactorial, including growth hormone (GH) deficiency, spinal irradiation effects, chemotherapy, poor nutrition, and tumor recurrence.
- Radiation-induced damage to the hypothalamic-pituitary axis is a primary cause of GH deficiency, potentially leading to panhypopituitarism with higher doses.
Purpose of the Study:
- To evaluate the efficacy of growth hormone (GH) therapy in improving growth rates in childhood brain tumor survivors with radiation-induced GH deficiency.
- To highlight other potential endocrine complications following spinal irradiation.
Main Methods:
- This study focuses on preliminary results and observations rather than a specific experimental methodology.
- Analysis of growth data in patients receiving GH therapy.
Main Results:
- Preliminary results suggest that growth hormone (GH) therapy can enhance the growth rate in children with GH deficiency secondary to radiation treatment.
- Spinal irradiation can also lead to other endocrine issues like thyroid dysfunction and ovarian failure.
Conclusions:
- Growth hormone (GH) therapy shows promise for improving height in childhood brain tumor survivors with radiation-induced GH deficiency.
- Comprehensive endocrine monitoring is crucial for managing survivors due to the risk of multiple pituitary and gonadal hormone deficiencies.
Abstract:
The adult survivors of the treatment of brain tumours in childhood are often short. Several adverse factors contribute to the impaired growth of these children including growth hormone (GH) deficiency, impaired spinal growth following spinal irradiation, chemotherapy, poor nutritional intake and recurrent tumour. The GH deficiency is due to radiation-induced damage to the hypothalamic-pituitary axis. GH is always the first pituitary hormone to be affected by such radiation damage but panhypopituitarism may occur if the radiation dose is sufficiently great. Preliminary results suggest that GH therapy will improve the growth rate of children with radiation-induced GH deficiency. Additional endocrine complications, which may occur following spinal irradiation, include thyroid dysfunction and ovarian failure due to direct radiation damage to the thyroid and the ovary.
